Compliance office restructuring
This article was originally published in The Gray Sheet
Executive SummaryDevice center's Office of Compliance consolidates its structure by forming three branches in each enforcement division instead of four. The general hospital branch has been combined with the urology and gastroenterology branch; the ophthalmic group has been folded into the dental and ear, nose and throat branch; and the orthopedic and physical medicine branch has merged with the anesthesiology group.
You may also be interested in...
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.
Consumer health product firms say the coronavirus will have an impact on their results, but it’s too early to estimate the costs. US FDA also hedges its predictions, saying the outbreak could lead to interruptions in country’s drug and medical device supplies. China's health commission has issued six guidelines for diagnosis and treatment, but no conventional antiviral treatment is approved and it's emphasizing traditional Chinese medicines.
With less than one hundred days left before the European Union Medical Device Regulations kick in, Medtech Insight’s executive editor Ashley Yeo and managing editor Amanda Maxwell discuss growing concerns by medtech industry members that they may not be ready in time to comply with these regulations and may inadvertently go afoul of the new regulations.